Static Chart NFL Biosciences

Stocks

Market Closed - Euronext Paris 11:55:00 2026-09-30 EDT			5-day change	1st Jan Change
0.6900 ^EUR	-5.48%		-6.25%	-41.43%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

Duration

Period